Rupali Mukherjee
By
Rupali Mukherjee
Published: June 8, 2016, 7:52 p.m.·
Tags:
Treatment,
Access
The much-delayed daily regimen of tuberculosis will be rolled out by the government in a phased manner across the country by October this year. The rollout of the daily drug therapy, considered a game changer in the fight against tuberculosis by experts, doctors and activists, was to be piloted under the Revised National Tuberculosis Control Programme (RNTCP) in five states by March, after a delay of roughly two years.
Read More →
By
Rupali Mukherjee
Published: Aug. 18, 2015, 9:46 a.m.·
Tags:
Drug-resistant TB,
Advocacy
Health organizations, public health experts and patient groups have asked the government to take action to reduce the risk of healthcare workers from contracting tuberculosis at Mumbai-based Sewri Hospital - Asia's largest TB hospital. This comes in the wake of the recent death of a senior doctor who died of a potent form of multi- drug-resistant TB, falling prey to the infection which he reportedly acquired at the hospital.
Read More →
By
Rupali Mukherjee
Published: July 9, 2015, 3:18 p.m.·
Tags:
TB programs
MUMBAI: After a slash in India's healthcare budget and key public health initiatives, now the country's ambitious tuberculosis control programme is facing a serious challenge, which could jeopardise supply of medicines, and lead to inadequate diagnostic services for TB patients.
Read More →
By
Rupali Mukherjee
Published: Dec. 15, 2014, 6:21 p.m.·
Tags:
Access,
Pharma industry
MUMBAI: Some multinational companies (MNCs) have been delaying the launch of life-saving drugs in India years after getting monopoly rights, while cheaper generic versions of exorbitantly-priced medicines are going off the shelves under the product patenting law.
Read More →
By
Rupali Mukherjee
Published: Oct. 27, 2014, 12:30 p.m.·
Tags:
TB epidemiology,
Drug-resistant TB,
HIV coinfection
A new study points to an alarmingly high burden of drug-resistant tuberculosis (DR-TB) among HIV-positive patients at antiretroviral therapy (ART) centres, and provides evidence that primary transmission is the cause of DR-TB in as many as one in four newly-diagnosed TB patients.
Read More →
Page 1 of 1 · Total posts: 5
1